Literature DB >> 26429912

Structural Basis for Clonal Diversity of the Public T Cell Response to a Dominant Human Cytomegalovirus Epitope.

Xinbo Yang1, Mingming Gao1, Guobing Chen2, Brian G Pierce3, Jinghua Lu4, Nan-Ping Weng2, Roy A Mariuzza5.   

Abstract

Cytomegalovirus (CMV) is a ubiquitous and persistent human pathogen that is kept in check by CD8(+) cytotoxic T lymphocytes. Individuals expressing the major histocompatibility complex (MHC) class I molecule HLA-A2 produce cytotoxic T lymphocytes bearing T cell receptors (TCRs) that recognize the immunodominant CMV epitope NLVPMVATV (NLV). The NLV-specific T cell repertoire is characterized by a high prevalence of TCRs that are frequently observed in multiple unrelated individuals. These public TCRs feature identical, or nearly identical, complementarity-determining region 3α (CDR3α) and/or CDR3β sequences. The TCRs may express public CDR3α motifs alone, public CDR3β motifs alone, or dual public CDR3αβ motifs. In addition, the same public CDR3α motif may pair with different CDR3β motifs (and the reverse), giving rise to highly diverse NLV-specific TCR repertoires. To investigate the structural underpinnings of this clonal diversity, we determined crystal structures of two public TCRs (C7 and C25) in complex with NLV·HLA-A2. These TCRs utilize completely different CDR3α and CDR3β motifs that, in addition, can associate with multiple variable α and variable β regions in NLV-specific T cell repertoires. The C7·NLV·HLA-A2 and C25·NLV·HLA-A2 complexes exhibit divergent TCR footprints on peptide-MHC such that C25 is more focused on the central portion of the NLV peptide than is C7. These structures combined with molecular modeling show how the public CDR3α motif of C25 may associate with different variable α regions and how the public CDR3α motif of C7 may pair with different CDR3β motifs. This interchangeability of TCR V regions and CDR3 motifs permits multiple structural solutions to binding an identical peptide-MHC ligand and thereby the generation of a clonally diverse public T cell response to CMV.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  T-cell receptor (TCR); complex; herpesvirus; major histocompatibility complex (MHC); x-ray crystallography

Mesh:

Substances:

Year:  2015        PMID: 26429912      PMCID: PMC4661422          DOI: 10.1074/jbc.M115.691311

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

1.  A direct estimate of the human alphabeta T cell receptor diversity.

Authors:  T P Arstila; A Casrouge; V Baron; J Even; J Kanellopoulos; P Kourilsky
Journal:  Science       Date:  1999-10-29       Impact factor: 47.728

2.  Crystal structure of a T cell receptor bound to an allogeneic MHC molecule.

Authors:  J B Reiser; C Darnault; A Guimezanes; C Grégoire; T Mosser; A M Schmitt-Verhulst; J C Fontecilla-Camps; B Malissen; D Housset; G Mazza
Journal:  Nat Immunol       Date:  2000-10       Impact factor: 25.606

3.  Ex vivo induction and expansion of antigen-specific cytotoxic T cells by HLA-Ig-coated artificial antigen-presenting cells.

Authors:  Mathias Oelke; Marcela V Maus; Dominic Didiano; Carl H June; Andreas Mackensen; Jonathan P Schneck
Journal:  Nat Med       Date:  2003-04-21       Impact factor: 53.440

4.  Stable, soluble T-cell receptor molecules for crystallization and therapeutics.

Authors:  Jonathan M Boulter; Meir Glick; Penio T Todorov; Emma Baston; Malkit Sami; Pierre Rizkallah; Bent K Jakobsen
Journal:  Protein Eng       Date:  2003-09

Review 5.  Latency and reactivation of human cytomegalovirus.

Authors:  J G P Sissons; M Bain; M R Wills
Journal:  J Infect       Date:  2002-02       Impact factor: 6.072

6.  A structural basis for the selection of dominant alphabeta T cell receptors in antiviral immunity.

Authors:  Lars Kjer-Nielsen; Craig S Clements; Anthony W Purcell; Andrew G Brooks; James C Whisstock; Scott R Burrows; James McCluskey; Jamie Rossjohn
Journal:  Immunity       Date:  2003-01       Impact factor: 31.745

7.  Likelihood-enhanced fast rotation functions.

Authors:  Laurent C Storoni; Airlie J McCoy; Randy J Read
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-02-25

8.  Lytic versus stimulatory synapse in cytotoxic T lymphocyte/target cell interaction: manifestation of a dual activation threshold.

Authors:  Mustapha Faroudi; Clemens Utzny; Mariolina Salio; Vincenzo Cerundolo; Martine Guiraud; Sabina Müller; Salvatore Valitutti
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-10       Impact factor: 11.205

9.  A structural basis for immunodominant human T cell receptor recognition.

Authors:  Guillaume B E Stewart-Jones; Andrew J McMichael; John I Bell; David I Stuart; E Yvonne Jones
Journal:  Nat Immunol       Date:  2003-06-08       Impact factor: 25.606

10.  Characterization of human cytomegalovirus peptide-specific CD8(+) T-cell repertoire diversity following in vitro restimulation by antigen-pulsed dendritic cells.

Authors:  Karl Peggs; Stephanie Verfuerth; Arnold Pizzey; Jenni Ainsworth; Paul Moss; Stephen Mackinnon
Journal:  Blood       Date:  2002-01-01       Impact factor: 22.113

View more
  19 in total

1.  How structural adaptability exists alongside HLA-A2 bias in the human αβ TCR repertoire.

Authors:  Sydney J Blevins; Brian G Pierce; Nishant K Singh; Timothy P Riley; Yuan Wang; Timothy T Spear; Michael I Nishimura; Zhiping Weng; Brian M Baker
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-16       Impact factor: 11.205

2.  Sequence and Structural Analyses Reveal Distinct and Highly Diverse Human CD8+ TCR Repertoires to Immunodominant Viral Antigens.

Authors:  Guobing Chen; Xinbo Yang; Annette Ko; Xiaoping Sun; Mingming Gao; Yongqing Zhang; Alvin Shi; Roy A Mariuzza; Nan-Ping Weng
Journal:  Cell Rep       Date:  2017-04-18       Impact factor: 9.423

Review 3.  Emerging Concepts in TCR Specificity: Rationalizing and (Maybe) Predicting Outcomes.

Authors:  Nishant K Singh; Timothy P Riley; Sarah Catherine B Baker; Tyler Borrman; Zhiping Weng; Brian M Baker
Journal:  J Immunol       Date:  2017-10-01       Impact factor: 5.422

4.  Human cytomegalovirus-specific T-cell receptor engineered for high affinity and soluble expression using mammalian cell display.

Authors:  Ellen K Wagner; Ahlam N Qerqez; Christopher A Stevens; Annalee W Nguyen; George Delidakis; Jennifer A Maynard
Journal:  J Biol Chem       Date:  2019-02-22       Impact factor: 5.157

5.  Modeling and Viewing T Cell Receptors Using TCRmodel and TCR3d.

Authors:  Ragul Gowthaman; Brian G Pierce
Journal:  Methods Mol Biol       Date:  2020

6.  Structural basis for clonal diversity of the human T-cell response to a dominant influenza virus epitope.

Authors:  Xinbo Yang; Guobing Chen; Nan-Ping Weng; Roy A Mariuzza
Journal:  J Biol Chem       Date:  2017-09-20       Impact factor: 5.157

7.  Antigen identification for HLA class I- and HLA class II-restricted T cell receptors using cytokine-capturing antigen-presenting cells.

Authors:  Mark N Lee; Matthew Meyerson
Journal:  Sci Immunol       Date:  2021-01-22

8.  Design and Synthesis of Non-Peptide Mimetics Mapping the Immunodominant Myelin Basic Protein (MBP83-96) Epitope to Function as T-Cell Receptor Antagonists.

Authors:  Mary-Patricia Yannakakis; Carmen Simal; Haralambos Tzoupis; Maria Rodi; Narges Dargahi; Monica Prakash; Athanasia Mouzaki; James A Platts; Vasso Apostolopoulos; Theodore V Tselios
Journal:  Int J Mol Sci       Date:  2017-06-08       Impact factor: 5.923

9.  Broad TCR repertoire and diverse structural solutions for recognition of an immunodominant CD8+ T cell epitope.

Authors:  InYoung Song; Anna Gil; Rabinarayan Mishra; Dario Ghersi; Liisa K Selin; Lawrence J Stern
Journal:  Nat Struct Mol Biol       Date:  2017-02-27       Impact factor: 15.369

10.  Massively parallel interrogation and mining of natively paired human TCRαβ repertoires.

Authors:  Matthew J Spindler; Ayla L Nelson; Ellen K Wagner; Natasha Oppermans; John S Bridgeman; James M Heather; Adam S Adler; Michael A Asensio; Robert C Edgar; Yoong Wearn Lim; Everett H Meyer; Robert E Hawkins; Mark Cobbold; David S Johnson
Journal:  Nat Biotechnol       Date:  2020-03-16       Impact factor: 54.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.